Following a highly valuable tenure, Ziccum’s co-founder and former Chairman Fredrik Sjövall is handing over to Jonas Ekblom, who has been elected Chairman of the Board at Ziccum’s AGM on May 29th, during which Ziccum also added a new member, Valentina Screpanti Sundquist.
Jonas Ekblom
Jonas has over 25 years’ experience in life science and is Associate Professor of Pharmacology at Uppsala University. He has held senior and executive management roles in biotechnology companies in Sweden, the USA and Switzerland, in companies such as Pharmacia, Biovitrum, Promore Pharma, Sequenom, Invitrogen, Pergamum AB and BOWS Pharmaceuticals SA. He is currently Chairman of the board of CombiGene AB (publ) and Oblique Therapeutics AB (publ) and board member of Emplipharm AB (publ) and Moberg Pharma AB (publ).
Valentina Screpanti Sundquist
With almost 20 years’ experience in life science, Valentina Screpanti Sundquist currently is at vaccine company Valneva. She also represents Sweden on behalf of the Swedish Medical Products Agency in the expert group 15, human vaccines and sera, at the European Pharmacopoeia, European Directorate for the Quality of Medicines HealthCare (EDQM, Council of Europe). Valentina has held roles in Swedish biotechnology companies such as BioArctic Neuroscience, Astra Zeneca and Crucell (Johnson and Johnson).
Ziccum CEO Ann Gidner: “we are delighted to welcome two new members to the Ziccum Board, including a Chairman with such an excellent profile and network in industry. Their appointments underline the continued advancement and development of Ziccum. Meanwhile, I want to extend our warmest gratitude to Fredrik Sjövall, who was instrumental in creating Ziccum and taking it forward to the position where it is today. The recent, significant company development has been possible only thanks to his highly engaged support”.